Concept information
اصطلاح مرجح
sialopentaosylceramide
نوع
-
http://www.irandoc.ac.ir/onto/irandoc-meta/Concept
مفهوم اعم
مفهومهای اخص
- alpha-l-fuc-(1->2)-beta-d-gal-(1->3)-beta-d-galnac-(1->4)-[alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
- alpha-neu5ac-(2->3)-beta-d-gal-(1->3)-[alpha-l-fuc-(1->4)]-[alpha-neu5ac-(2->6)]-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
- alpha-neu5ac-(2->3)-beta-d-gal-(1->3)-[alpha-l-fuc-(1->4)]-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
- alpha-neu5ac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->4)-[alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer(d18:1/20:0)
- alpha-neu5ac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->4)-[alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer(d18:1/22:0)
- alpha-neu5ac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->4)-[alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer(d18:1/22:1)
- alpha-neu5ac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->4)-[alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer(d18:1/23:0)
- alpha-neu5ac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->4)-[alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer(d18:1/24:0)
- alpha-neu5ac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->4)-[alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer(d18:1/24:1(15z))
- alpha-neu5ac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->4)-[alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer(d18:1/24:2)
- alpha-neu5ac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->4)-[alpha-neu5ac-(2->8)-alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer(d18:1/18:0)
- alpha-neu5ac-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->4)-[alpha-neu5ac-(2->8)-alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer(d18:1/22:0)
- alpha-neu5ac-(2->3)-beta-d-gal (1->4)-[alpha-l-fuc-(1->3)]-beta-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
- alpha-neu5ac-(2->3)-beta-d-gal-(1->4)-[alpha-l-fuc-(1->3)]-beta-d-glcnac6s-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer(d18:1/18:0)
- alpha-neu5d5n;1,5-lactam-(2->3)-beta-d-gal-(1->4)-[alpha-l-fuc-(1->3)]-beta-d-glcnac6s-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer(d18:1/18:0)
- alpha-neu5gc-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
- alpha-neu5gc-(2->8)-alpha-neu5gc-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
- beta-d-galnac-(1->4)-[alpha-neu5ac-(2->3)]-beta-d-gal-(1->3)-alpha-d-glcnac-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
- beta-d-galnac-(1->4)-[alpha-neu5ac-(2->3)]-beta-d-gal-(1->3)-beta-d-galnac-(1->4)-[alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
- beta-d-galnac-(1->4)-[alpha-neu5ac-(2->3)]-beta-d-gal-(1->3)-beta-d-galnac-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
- beta-d-galnac-(1->4)-[alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-galnac-(1->3)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
- beta-galnac-(1->4)-[alpha-neu5ac-(2->3)]-beta-gal-(1->3)-beta-glcnac-(1->3)-beta-gal-(1->4)-beta-glc-(1->1')-cer
- n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-beta-d-galactosaminyl-(1->4)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-)
- n-acetyl-alpha-neuraminosyl-(2->3)-n-acetyl-beta-d-galactosaminyl-(1->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-)
- n-acetyl-alpha-neuraminosyl-(2->3)-[n-acetyl-beta-d-galactosaminyl-(1->4)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-)
- n-acetyl-beta-d-galactosaminyl-(1->4)-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-)
- n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-)
زیرمجموعه
- 3_STAR
در زبان های دیگر
-
Persian
URI
http://www.irandoc.acir/onto/irandoc/CHEBI:36542
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}